[filleokus]

Having a time limited monopoly on new drugs seems required considering the costs involved in getting drugs through the regulatory framework.

[paulryanrogers]

Considering how much more is spent on marketing and executive salaries, maybe we don't?

Or the patent protection is contingent on limits to marketing and admin overhead